These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16014539)
1. A deiminated viral peptide to detect antibodies in rheumatoid arthritis. Merlini G; Anzilotti C; Chimenti D; Tommasi C; Bombardieri S; Migliorini P Ann N Y Acad Sci; 2005 Jun; 1050():243-9. PubMed ID: 16014539 [TBL] [Abstract][Full Text] [Related]
2. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
3. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders. Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [TBL] [Abstract][Full Text] [Related]
5. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Pratesi F; Tommasi C; Anzilotti C; Chimenti D; Migliorini P Arthritis Rheum; 2006 Mar; 54(3):733-41. PubMed ID: 16508937 [TBL] [Abstract][Full Text] [Related]
6. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543 [TBL] [Abstract][Full Text] [Related]
7. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Chapuy-Regaud S; Nogueira L; Clavel C; Sebbag M; Vincent C; Serre G Clin Exp Immunol; 2005 Mar; 139(3):542-50. PubMed ID: 15730401 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Vander Cruyssen B; Cantaert T; Nogueira L; Clavel C; De Rycke L; Dendoven A; Sebag M; Deforce D; Vincent C; Elewaut D; Serre G; De Keyser F Arthritis Res Ther; 2006; 8(4):R122. PubMed ID: 16859515 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988 [TBL] [Abstract][Full Text] [Related]
10. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X; Jia R; Zhao J; Li Z J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936 [TBL] [Abstract][Full Text] [Related]
11. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis]. Tian X; Bi LQ; Li ZG Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630 [TBL] [Abstract][Full Text] [Related]
12. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test? Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and significance of antibodies to citrullinated human papilloma virus-47 E2345-362 in rheumatoid arthritis. Shi J; Sun X; Zhao Y; Zhao J; Li Z J Autoimmun; 2008 Sep; 31(2):131-5. PubMed ID: 18511237 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Dejaco C; Klotz W; Larcher H; Duftner C; Schirmer M; Herold M Arthritis Res Ther; 2006; 8(4):R119. PubMed ID: 16859519 [TBL] [Abstract][Full Text] [Related]
15. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus. Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267 [TBL] [Abstract][Full Text] [Related]
16. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor. Vander Cruyssen B; Peene I; Cantaert T; Hoffman IE; De Rycke L; Veys EM; De Keyser F Autoimmun Rev; 2005 Sep; 4(7):468-74. PubMed ID: 16137613 [TBL] [Abstract][Full Text] [Related]
18. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis. Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452 [TBL] [Abstract][Full Text] [Related]
19. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease. Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599 [TBL] [Abstract][Full Text] [Related]
20. [The new serological markers of rheumatoid arthritis]. Tuchocka-Piotrowska A; Puszczewicz M Pol Merkur Lekarski; 2007 Sep; 23(135):215-20. PubMed ID: 18080699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]